Response to the article by Kwak et al entitled "No increased incidence of Clostridium difficile infection among patients with hidradenitis suppurativa treated with systemic clindamycin"

J Am Acad Dermatol. 2022 Jul;87(1):e17-e18. doi: 10.1016/j.jaad.2022.02.052. Epub 2022 Mar 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Clindamycin / adverse effects
  • Clostridium Infections* / drug therapy
  • Clostridium Infections* / epidemiology
  • Hidradenitis Suppurativa* / drug therapy
  • Hidradenitis Suppurativa* / epidemiology
  • Humans
  • Incidence

Substances

  • Anti-Bacterial Agents
  • Clindamycin